In vivo pharmacodynamics of piperacillin/tazobactam: implications for antimicrobial efficacy and resistance suppression with innovator and generic products
CA Rodriguez, M Agudelo, AF Zuluaga… - International journal of …, 2017 - Elsevier
Recent studies have shown that the pharmacodynamic (PD) index driving the efficacy of β-
lactam/β-lactamase inhibitor combinations such as ceftazidime/avibactam and ceftolozane …
lactam/β-lactamase inhibitor combinations such as ceftazidime/avibactam and ceftolozane …
In vivo pharmacodynamics of piperacillin/tazobactam: implications for antimicrobial efficacy and resistance suppression with innovator and generic products
CA Rodriguez, M Agudelo… - International journal …, 2017 - pubmed.ncbi.nlm.nih.gov
Recent studies have shown that the pharmacodynamic (PD) index driving the efficacy of β-
lactam/β-lactamase inhibitor combinations such as ceftazidime/avibactam and ceftolozane …
lactam/β-lactamase inhibitor combinations such as ceftazidime/avibactam and ceftolozane …
In vivo pharmacodynamics of piperacillin/tazobactam: implications for antimicrobial efficacy and resistance suppression with innovator and generic products.
CA Rodriguez, M Agudelo, AF Zuluaga, O Vesga - 2017 - cabidigitallibrary.org
Recent studies have shown that the pharmacodynamic (PD) index driving the efficacy of β-
lactam/β-lactamase inhibitor combinations such as ceftazidime/avibactam and ceftolozane …
lactam/β-lactamase inhibitor combinations such as ceftazidime/avibactam and ceftolozane …
In vivo pharmacodynamics of piperacillin/tazobactam: implications for antimicrobial efficacy and resistance suppression with innovator and generic products
CA Rodriguez, M Agudelo, AF Zuluaga… - International Journal of …, 2017 - infona.pl
Recent studies have shown that the pharmacodynamic (PD) index driving the efficacy of β-
lactam/β-lactamase inhibitor combinations such as ceftazidime/avibactam and ceftolozane …
lactam/β-lactamase inhibitor combinations such as ceftazidime/avibactam and ceftolozane …
In vivo pharmacodynamics of piperacillin/tazobactam: implications for antimicrobial efficacy and resistance suppression with innovator and generic products.
CA Rodriguez, M Agudelo, AF Zuluaga… - International Journal of …, 2016 - europepmc.org
Recent studies have shown that the pharmacodynamic (PD) index driving the efficacy of β-
lactam/β-lactamase inhibitor combinations such as ceftazidime/avibactam and ceftolozane …
lactam/β-lactamase inhibitor combinations such as ceftazidime/avibactam and ceftolozane …